查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2053045

全球體外膜氧合（ECMO）市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Extracorporeal Membrane Oxygenation Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 164 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球體外膜氧合（ECMO）市場預計將從2025年的4.9188億美元成長至2034年的7.5267億美元，2026年至2034年的複合年成長率（CAGR）為4.84%。該市場正經歷顯著成長，主要原因是全球嚴重呼吸系統和心臟疾病的盛行率不斷上升。 ECMO系統為患有嚴重心臟衰竭衰竭的患者提供生命維持。對先進的緊急醫療解決方案日益成長的需求以及ECMO在複雜手術中應用的不斷廣泛，正強勁推動著市場擴張。此外，氧合設備和監測系統的技術進步也正在改善全球的治療效果和患者存活率。

心血管疾病、呼吸道感染疾病和器官衰竭病例的不斷增加是推動市場成長的主要因素。醫院和加護病房擴大採用體外膜氧合（ECMO）系統進行緊急和長期重症監護管理。醫療保健支出的成長和專業重症監護設施的擴建也進一步促進了產品的普及。此外，人們對先進生命維持療法的認知不斷提高以及醫療保健服務可近性的改善也對全球市場產生了積極影響。

由於攜帶式和小型生命維持系統的不斷進步，體外膜氧合（ECMO）市場仍然前景廣闊。致力於提升設備安全性、效率和病患監測能力的研究活動預計將進一步促進未來的成長。在新興市場，醫療基礎設施的擴建和重症監護投入的增加預計將推動ECMO的進一步普及。隨著對先進呼吸和心臟支援技術的需求持續成長，預計ECMO市場將保持持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球體外膜氧合（ECMO）市場：依模式分類

  • 市場分析、洞察與預測
  • 靜脈動脈（VA）
  • 靜脈對靜脈（VV）
  • 動靜脈（AV）

第5章 全球體外膜氧合（ECMO）市場：依應用分類

  • 市場分析、洞察與預測
  • 心臟病
  • 呼吸系統疾病
  • 體外心肺復甦術（ECPR）

第6章 全球體外膜氧合（ECMO）市場：依病患群體分類

  • 市場分析、洞察與預測
  • 嬰兒
  • 兒童
  • 成人

第7章 全球體外膜氧合（ECMO）市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Abiomed
    • Eurosets
    • Braile Biomedica
    • Edwards Lifesciences Corporation
    • Fresenius Medical Care AG & Co. KGaA
    • Getinge AB
    • Hemovent GmbH
    • LivaNova PLC
    • Medtronic
    • MicroPort Scientific Corporation
    • Nipro
    • SB-Kawasumi LaboratoriesInc
    • Senko Medical Instrument Mfg. Co.Ltd
    • Spectrum Medical, Terumo Corporation
    • Weigao Group Co.Ltd
簡介目錄
Product Code: VMR112118195

The global extracorporeal membrane oxygenation market size is expected to reach USD 752.67 Million in 2034 from USD 491.88 Million in 2025, growing at a CAGR of 4.84 during 2026-2034.This market is witnessing significant growth due to rising prevalence of severe respiratory and cardiac disorders worldwide. Extracorporeal membrane oxygenation systems provide life-support assistance for patients experiencing critical heart or lung failure. Increasing demand for advanced critical care solutions and growing use of ECMO during complex surgeries are strongly supporting market expansion. Technological advancements in oxygenation devices and monitoring systems are also improving treatment outcomes and patient survival rates globally.

Growing incidence of cardiovascular diseases, respiratory infections, and organ failure cases are major drivers influencing market growth. Hospitals and intensive care units are increasingly adopting ECMO systems for emergency and long-term critical care management. Rising healthcare expenditure and expansion of specialized critical care facilities are further boosting product adoption. In addition, increasing awareness regarding advanced life-support therapies and improved access to healthcare services are positively impacting the global market.

Future prospects for the ECMO market remain highly promising due to ongoing advancements in portable and compact life-support systems. Research activities focused on improving device safety, efficiency, and patient monitoring capabilities are expected to strengthen future growth. Emerging economies are likely to witness increased adoption because of expanding healthcare infrastructure and critical care investments. As demand for advanced respiratory and cardiac support technologies continues rising, the market is projected to experience sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Modality

  • Venoarterial (VA)
  • Veno-venous (VV)
  • Arteriovenous (AV)

By Application

  • Cardiac Diseases
  • Respiratory Diseases
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Patient Population

  • Infant
  • Pediatric
  • Adult

COMPANIES PROFILED

  • Abbott Laboratories, Abiomed, Eurosets, Braile Biomedica, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Nipro, SB-Kawasumi Laboratories, Inc., Senko Medical Instrument Mfg. Co., Ltd., Spectrum Medical, Terumo Corporation, Weigao Group Co., Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY MODALITY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Modality
  • 4.2. Venoarterial (VA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Veno-venous (VV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Arteriovenous (AV) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Cardiac Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY PATIENT POPULATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Patient Population
  • 6.2. Infant Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Modality
    • 7.2.2 By Application
    • 7.2.3 By Patient Population
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Modality
    • 7.3.2 By Application
    • 7.3.3 By Patient Population
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Modality
    • 7.4.2 By Application
    • 7.4.3 By Patient Population
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Modality
    • 7.5.2 By Application
    • 7.5.3 By Patient Population
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Modality
    • 7.6.2 By Application
    • 7.6.3 By Patient Population
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Abiomed
    • 9.2.3 Eurosets
    • 9.2.4 Braile Biomedica
    • 9.2.5 Edwards Lifesciences Corporation
    • 9.2.6 Fresenius Medical Care AG & Co. KGaA
    • 9.2.7 Getinge AB
    • 9.2.8 Hemovent GmbH
    • 9.2.9 LivaNova PLC
    • 9.2.10 Medtronic
    • 9.2.11 MicroPort Scientific Corporation
    • 9.2.12 Nipro
    • 9.2.13 SB-Kawasumi LaboratoriesInc
    • 9.2.14 Senko Medical Instrument Mfg. Co.Ltd
    • 9.2.15 Spectrum Medical, Terumo Corporation
    • 9.2.16 Weigao Group Co.Ltd